Conference pass
The next big immune checkpoint: LAG-3
Immunotherapy
- The potential of LAG-3 in immune oncology and autoimmune diseases
- Combination therapy as a key therapeutic strategy in oncology
- Collaborations as a path to success in global drug development
#
Marc Voigt,Chief Executive Officer,Immutep Lt
3.20pm 1st of March........Seems to be a business orchestrated Conference.....
Asia presentation
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $447.2M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.5¢ | 29.0¢ | $1.805M | 5.903M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 193400 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |